Close Rachel N, Schoeller Dale A, Watras Abigail C, Nora Elizabeth H
Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Am J Clin Nutr. 2007 Sep;86(3):797-804. doi: 10.1093/ajcn/86.3.797.
Conjugated linoleic acid (CLA) is a family of positional and geometric isomers with 2 conjugated double bonds formed from linoleic acid and linolenic acid. CLA has a wide range of biological effects, including body fat reduction.
The aim of our study was to determine CLA's effects on energy expenditure, macronutrient utilization, and dietary fat oxidation in overweight adults after 6 mo of supplementation.
We recruited 23 subjects from our main CLA efficacy study who were receiving either 4 g/d of 78% active CLA isomers (3.2 g/d: 39.2% cis-9,trans-11 and 38.5% trans-10,cis-12) or 4 g/d of safflower oil. Energy expenditure and substrate utilization were measured before and after 6 mo of CLA supplementation by using whole-room indirect calorimetry. Dietary fat oxidation was measured by using stable isotope-labeled oleate and palmitate.
Our substudy detected a difference in the change in fat utilization between the CLA (4 +/- 8 g) and placebo (-7 +/- 11 g) groups during sleep after 6 mo of supplementation. In addition, the percentage of energy from protein was reduced during sleep in the CLA group (CLA: -3.3 +/- 2.6%; placebo: 0.3 +/- 5.7%). We also detected a difference in the change in energy expenditure during sleep (CLA: 0 +/- 38 kcal; placebo: -43 +/- 90 kcal). We did not detect a change in labeled dietary fat oxidation after 6 mo of CLA supplementation given with a breakfast meal.
Mixed isomer CLA supplementation, but not placebo, positively altered fat oxidation and energy expenditure during sleep.
共轭亚油酸(CLA)是由亚油酸和亚麻酸形成的具有2个共轭双键的位置和几何异构体家族。CLA具有广泛的生物学效应,包括减少体脂。
我们研究的目的是确定补充CLA 6个月后对超重成年人能量消耗、常量营养素利用和膳食脂肪氧化的影响。
我们从主要的CLA功效研究中招募了23名受试者,他们分别接受4 g/d的78%活性CLA异构体(3.2 g/d:39.2%顺式-9,反式-11和38.5%反式-10,顺式-12)或4 g/d的红花油。在补充CLA 6个月前后,通过全室间接测热法测量能量消耗和底物利用情况。通过使用稳定同位素标记的油酸和棕榈酸测量膳食脂肪氧化。
我们的子研究发现,补充CLA 6个月后,CLA组(4±8 g)和安慰剂组(-7±11 g)在睡眠期间脂肪利用变化存在差异。此外,CLA组在睡眠期间来自蛋白质的能量百分比降低(CLA:-3.3±2.6%;安慰剂:0.3±5.7%)。我们还检测到睡眠期间能量消耗变化存在差异(CLA:0±38千卡;安慰剂:-43±90千卡)。在早餐时补充CLA 6个月后,我们未检测到标记膳食脂肪氧化的变化。
补充混合异构体CLA而非安慰剂可积极改变睡眠期间的脂肪氧化和能量消耗。